MKI67 and breast cancer: Because Ki67 is an indicator of BC proliferation and is important in determining whether chemotherapy should be administered [32,38], our finding suggests that α-parvin could be a marker for deciding on the use of chemotherapy, and α-parvin may be a potential therapeutic target for BC with high cell proliferative potential.